Search Results - "Ananda, Sumitra S"

Initial impact of Australia's National Bowel Cancer Screening Program by Ananda, Sumitra S, McLaughlin, Stephen J, Chen, Frank, Hayes, Ian P, Hunter, Andrew A, Skinner, Iain J, Steel, Malcolm C A, Jones, Ian T, Hastie, Ian A, Rieger, Nicholas A, Shedda, Susan, Compston, Daniel J, Gibbs, Peter

“…Objective: To examine the initial impact of the National Bowel Cancer Screening Program (NBCSP), which was launched in May 2006 and offers faecal occult blood…”
Get full text

Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer by Loft, Matthew, Shapiro, Jeremy, Lee, Margaret, Wong, Rachel, Tie, Jeanne, Kosmider, Suzanne, Wong, Vanessa, Jalali, Azim, Lee, Belinda, Ananda, Sumitra S., Gibbs, Peter

“…Abstract Background Treatment with cetuximab provides a survival benefit for patients with RAS wild‐type metastatic colorectal cancer (mCRC). Practice‐defining…”
Get full text

Quality of pathology reporting impacts on lymph node yield in colon cancer by Rieger, Nicholas A, Barnett, Frances S, Moore, James W E, Ananda, Sumitra S, Croxford, Matthew, Johns, Julie, Gibbs, Peter

Get full text

Characteristics and outcomes for fecal occult blood test (FOBT) screen detected (SD) versus non-screen detected (NSD) colorectal cancer (CRC) by Mendis, Shehara Ramyalini, Ananda, Sumitra S, Hong, Wei, Faragher, Ian, Croxford, Matthew, Jones, Ian, Steel, Malcolm, Jalali, Azim, Gard, Grace, To, Yat Hang, Lee, Margaret, Kosmider, Suzanne, Wong, Rachel, Tie, Jeanne, Gibbs, Peter

“…Abstract only 42 Background: FOBT based screening for CRC has been shown in multiple studies to reduce CRC mortality. Beyond the well described earlier stage…”
Get full text

Real-world survival outcomes of using neoadjuvant chemotherapy in pancreatic cancer patients: Findings from the PURPLE clinical registry by Lee, Belinda, Witmond, Vincent, Pereira-Salgado, Amanda, Degeling, Koen, Shapiro, Julia, Thomson, Benjamin N, Ananda, Sumitra S, McLachlan, Sue-Anne, Knowles, Brett, Fox, Adrian, Wong, Rachel, Burge, Matthew E., Clarke, Kate, Pattison, Sharon Tracy, Nikfarjam, Mehrdad, Nagrial, Adnan, Zielinski, Rob, Chee, Cheng Ean, Gibbs, Peter, IJzerman, Maarten J.

“…Abstract only e16755 Background: Only a minority of pancreatic cancer patients (pts) are surgical candidates at presentation. Neoadjuvant chemotherapy (NAT) is…”
Get full text